drugset / Trial / NCT00889356
Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the Efficacy, Tolerability \& Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, used for 7 consecutive days in patients with Mixed-Type Vaginosis compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vaginal Cream.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amphotericin B | Unknown | 50 mg | Other |
| Subject | Clindamycin | Unknown | 100 mg | Other |
| Subject | Ketoconazole | Small molecule | 400 mg | Other |
| Comparator | Tetracycline | Unknown | 100 mg | Other |